Olmesartan HCT AN 20/25 olmesartan medoxomil/hydrochlorothiazide 20/25 mg film coated tablets blister pack

Country: Ավստրալիա

language: անգլերեն

source: Department of Health (Therapeutic Goods Administration)

active_ingredient:

hydrochlorothiazide, Quantity: 25 mg; olmesartan medoxomil, Quantity: 20 mg

MAH:

Amneal Pharma Australia Pty Ltd

INN:

Hydrochlorothiazide,Olmesartan medoxomil

pharmaceutical_form:

Tablet, film coated

composition:

Excipient Ingredients: lactose monohydrate; microcrystalline cellulose; purified water; hyprolose; hypromellose; magnesium stearate; titanium dioxide; iron oxide yellow; macrogol 4000

administration_route:

Oral

units_in_package:

30

prescription_type:

(S4) Prescription Only Medicine

therapeutic_indication:

Indicated for the treatment of hypertension.,Treatment should not be initiated with this fixed dose combination.

leaflet_short:

Visual Identification: 20/25 mg film coated tablets are yellow film coated, oval shaped, biconvex tablets debossed with L400 on one side and plain on other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

authorization_status:

Licence status A

authorization_date:

2015-02-05